Efficacy of Single Dose Rectal Diclofenac With Oral Diclofenac for the Relief of Perineal Pain Within 24 Hours After Episiotomy
NCT ID: NCT06220279
Last Updated: 2024-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
146 participants
INTERVENTIONAL
2021-06-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rectal Versus Oral Diclofenac Sodium in Relieving Post Episiotomy Pain
NCT04331210
Rectal Versus Intramuscular Diclofenac for Pain Relief Following Caesarean Section
NCT06845930
Piroxicam Versus Diclofenac for Post Caesarean Section Analgesia
NCT06943092
Effect of Intraoperative Intravenous Lidocaine on Postoperative Pain and Return of Bowel Function After Cesarean Sections
NCT06433713
The Role of Timing of Dexamethasone Administration on Pain Scores and Quality of Recovery in Cesarean Section.
NCT02112422
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim: To compare the efficacy of single dose rectal diclofenac with oral diclofenac for the relief of perineal pain within 24 hours after episiotomy repair at Alex Ekwueme Federal University Teaching Hospital Abakaliki.
Materials and Methods: This was a randomized controlled trial that involved 146 women that had episiorrhaphy between June and December 2020. The women were randomized into two groups of 73 women each using computer generated random numbers. One group received 100mg of diclofenac suppository stat while the other group received 2 doses of 50mg of oral diclofenac 12 hours apart, both for 24 hours after episiorrhaphy. Pain was assessed at 1, 4, 8, 16 and 24 hours post episiorraphy using a Visual Analogue Scale. Maternal satisfaction for the mode of the pain relief was assessed using the Likert scale after 24 hours. Data obtained was analyzed using Statistical Package for Social Science software version 25.
The perineal pain was categorized into: no pain (0cm), mild (1-3cm), moderate (4-7cm) and severe (8-10cm), while maternal satisfaction was categorized into: Very satisfied, Satisfied, Neutral, Dissatisfied, Very dissatisfied. Categorical variables were summarized using frequencies and proportion. Quantitative variables were summarized with means and standard deviation. Student t-test was used for comparison between the group means for continuous variables while Chi-squared test was used to compare categorical variables. Statistical significance was obtained when p-value was ≤ 0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1, oral diclofenac
Two doses of 50mg oral diclofenac 12 hours apart was administered to this arm
Diclofenac
Each were monitored for pain within 24 hours
Arm 2, rectal diclofenac
100mg diclofenac was administered rectally to this arm
Diclofenac
Each were monitored for pain within 24 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diclofenac
Each were monitored for pain within 24 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age of 37 weeks and above who had episiotomy
* Singleton gestation
* Vaginal delivery
* Instrumental vaginal delivery
* Consented women
Exclusion Criteria
* Postpartum hemorrhage.
* Women who had perineal tear
* History of peptic ulcer diseases
* History of bleeding coagulopathies
* Adverse reaction or hypersensitivity to diclofenac
* Any woman with special postpartum pain relief plan such as sickle cell disease patient
* Preeclamptic/eclamptic, renal and liver diseases patients.
* Parturient on epidural anesthesia
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal Teaching Hospital Abakaliki
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nwali Matthew Igwe
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alex Ekwueme Federal University Teaching Hospital
Abakaliki, Ebonyi State, Nigeria
Federal Teaching Hospital, Abakaliki
Abakaliki, Ebonyi State, Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRAEP2023CT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.